<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04966026</url>
  </required_header>
  <id_info>
    <org_study_id>M2017017</org_study_id>
    <nct_id>NCT04966026</nct_id>
  </id_info>
  <brief_title>Clinical Characteristics and Outcome of Patients With COPD With Pneumonia</brief_title>
  <official_title>Study on the Clinical Characteristics and Outcome of Patients With COPD Combined With Pneumonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To identify the clinical characteristics of patients with chronic obstructive pulmonary&#xD;
      disease (COPD) combined with community-acquired pneumonia (CAP) and the factors influencing&#xD;
      clinical transition.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To identify the clinical characteristics of patients with chronic obstructive pulmonary&#xD;
      disease (COPD) combined with community-acquired pneumonia (CAP) and the factors influencing&#xD;
      clinical transition.Compared to other chronic airway diseases, COPD patients can often have&#xD;
      CAP in combination, but there is a lack of comparative studies between COPD patients with CAP&#xD;
      and non-COPD patients with CAP.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Actual">May 30, 2018</completion_date>
  <primary_completion_date type="Actual">February 28, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mortality rate</measure>
    <time_frame>Day 28 from hospitalization</time_frame>
    <description>mortality rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of days in hospital</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Number of days in hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of days in ICU</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>number of days in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of days on mechanical ventilation</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>number of days on mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cause of using antimicrobial drugs</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Days of using antimicrobial drugs during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital fees</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>hospital fees.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">143</enrollment>
  <condition>Pneumonia</condition>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>COPD combined with CAP inpatients</arm_group_label>
    <description>(1) CAP meets the diagnostic criteria published in our 2016 CAP diagnosis and treatment guidelines; CPOPD and AECOPD meet the diagnostic criteria published in our 2013 COPD diagnosis and treatment guidelines; (2) age ≧ 18 years. Exclusion criteria: (1) age &lt;18 years; (2) pregnancy; (3) positive human immunodeficiency virus (HIV) antibody; (4) suspected or confirmed tuberculosis or fungal infection of the lung.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No inervention</intervention_name>
    <description>No inervention</description>
    <arm_group_label>COPD combined with CAP inpatients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with COPD combined with pneumonia admitted to Peking University Third Hospital&#xD;
        from March 1, 2017 to February 28, 2018&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. CAP meets the diagnostic criteria published in 2016 Chinese CAP diagnosis and&#xD;
             treatment guidelines; CPOPD and AECOPD meet the diagnostic criteria published in&#xD;
             Chinese 2013 COPD diagnosis and treatment guidelines;&#xD;
&#xD;
          2. Age ≧ 40years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. age &lt;40years;&#xD;
&#xD;
          2. pregnancy;&#xD;
&#xD;
          3. positive for human immunodeficiency virus (HIV) antibodies;&#xD;
&#xD;
          4. suspected or confirmed tuberculosis or fungal infection of the lung.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yongchang Sun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University 3rd Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>July 4, 2021</study_first_submitted>
  <study_first_submitted_qc>July 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2021</study_first_posted>
  <last_update_submitted>July 14, 2021</last_update_submitted>
  <last_update_submitted_qc>July 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

